Litcius/Paper detail

Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China

Yang Li, Ting Zhu, Tingting Shen, Wenqi Wu, Jia-qian Cao, Jiawei Sun, Jing Liu, Xuping Zhou, Caixia Jiang, Zhen Tang, Tong Liu, Lihua Chen, Hua Hu, Weifeng Luo

2022Journal of Affective Disorders20 citationsDOI

Topics & Concepts

PlaceboHamdDepression (economics)Internal medicineAnxietyRating scaleMoodBotulinum toxinAnhedoniaRandomized controlled trialMedicinePsychologyAnesthesiaPsychiatryAlternative medicineDevelopmental psychologyMacroeconomicsEconomicsPathologyDopamineBotulinum Toxin and Related Neurological DisordersNeurological disorders and treatmentsElectroconvulsive Therapy Studies
Botulinum toxin A (BoNT/A) for the treatment of depression: A randomized, double-blind, placebo, controlled trial in China | Litcius